Are brief febrile seizures benign? A systematic review and narrative synthesis

Laura Gould1,2, Victoria Delavale1,2, Caitlin Plovnick3

  • 1Comprehensive Epilepsy Center, NYU Langone Health, New York, New York, USA.

Epilepsia
|July 19, 2023
PubMed

Insights

Febrile seizures in children are generally benign but may rarely link to sudden death. Limited research exists on long-term outcomes, with some studies suggesting increased mortality risk in specific cases.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Epidemiology

Background:

  • Febrile seizures affect 2%-5% of U.S. children, often considered benign.
  • Concerns exist regarding potential links to epilepsy and rare sudden unexplained death.

Purpose of the Study:

  • To compare mortality, neurodevelopmental disorders, and neuropathology in children with simple and complex febrile seizures versus controls.
  • To systematically review existing literature on these outcomes.

Main Methods:

  • Systematic review of studies on children aged 3-72 months with febrile seizures ≤30 minutes.
  • Searched for outcomes on mortality, neurodevelopment, and neuropathology through July 18, 2022.
  • Assessed bias risk and stratified outcomes by study design.

Main Results:

  • Twenty-six studies (2665 children with febrile seizures, 1206 controls) were included.
  • Mortality data showed contrasts: cohort studies reported no deaths, while death series indicated 24.1% mortality.
  • Neurodevelopmental problems often predated febrile seizures; hippocampal anomalies noted in sudden deaths.

Conclusions:

  • Research on outcomes after simple or brief complex febrile seizures is limited.
  • Cohort studies had limitations (sample size, bias, follow-up duration).
  • Sudden death registries suggest a possible increased mortality risk associated with febrile seizures, warranting further long-term prospective studies.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
424
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
701
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
215
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
712
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
347
Patterns of Fever01:26

Patterns of Fever

Before understanding the types and patterns of fever, it is essential to know its phases.
2.7K